Overview
Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
Status:
Completed
Completed
Trial end date:
2011-12-01
2011-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is an efficacy study of Bromfenac Ophthalmic Solution in cataract surgery.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Bausch & Lomb IncorporatedTreatments:
Bromfenac
Ophthalmic Solutions
Pharmaceutical Solutions
Criteria
Inclusion Criteria:- Male or female at least 18 years of age who are scheduled for unilateral cataract
surgery
Exclusion Criteria:
- Have known hypersensitivity to bromfenac or to any component of the investigational
product